© 2020 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Press Releases
Targeted Oncology Adds Tennessee Oncology to Its Strategic Alliance Partnership Program
March 10, 2020
Targeted Oncology, a multimedia resource that offers engaging content and expert opinions on standard and emerging treatments in the field of oncology, announces the addition of Tennessee Oncology to their Strategic Alliance Partnership program.
Targeted Oncology Welcomes the Society of Hematologic Oncology to Its Strategic Alliance Partnership Program
January 08, 2020
Targeted Oncology, a multimedia resource that offers content and expert opinions on standard and emerging treatments in the oncology field, announces the addition of the Society of Hematologic Oncology to its Strategic Alliance Partnership program.
Targeted Oncology Welcomes the Medical Oncology Association of Southern California to Its Strategic Alliance Partnership Program
October 03, 2019
Targeted Oncology™, a multimedia resource that offers content and expert opinions on standard and emerging treatments in the oncology field, announces the addition of the Medical Oncology Association of Southern California (MOASC) to its Strategic Alliance Partnership program.
MJH Associates Announces Partnership with Hematology-Oncology Associates of Central New York
July 30, 2019
MJH Associates‚ Inc. announces a Strategic Alliance Partnership between Hematology-Oncology Associates of Central New York and Targeted Oncology.
Targeted Oncology Adds Carolina Blood and Cancer Care to Its Strategic Alliance Partnership Program
June 25, 2019
Targeted Oncology™ announces the addition of Carolina Blood and Cancer Care to their Strategic Alliance Partnership programs.
Targeted Oncology Adds The Florida Society of Clinical Oncology to Its Strategic Alliance Partnership Program
May 13, 2019
Targeted Oncology, a multimedia resource that offers content and expert opinions on standard and emerging treatments in the oncology field, announces the addition of The Florida Society of Clinical Oncology to its Strategic Alliance Partnership program.
Targeted Therapies in Oncology Welcomes Dr. Robert Ferris as Co-Physician Editor-In-Chief
November 08, 2018
Targeted Therapies in Oncology, an oncology publication that provides oncology professionals with cutting-edge research, data, and treatment strategies surrounding molecular and immune system targets, has appointed Robert L. Ferris, MD, PhD, as its co-physician editor-in-chief.
Targeted Oncology Launches its Latest Virtual Tumor Board on Multiple Myeloma
September 20, 2018
Targeted Oncology™ will launch its third “Expert Perspective: Virtual Tumor Board” on Monday, September 24. Each Virtual Tumor Board is a video-editorial discussion that features key opinion leaders from a specific oncological field considering options for treating patients based on case scenarios. This episode will focus on multiple myeloma.
Targeted Oncology Launches its Latest Virtual Tumor Board on NSCLC
September 12, 2018
Targeted Oncology, a print and digital resource that offers content and expert opinions on precision medicine in oncology, launched its second “Expert Perspective: Virtual Tumor Board” on Wednesday, September 12. The Virtual Tumor Board is a video-editorial board discussion that features key opinion leaders from a specific oncological field. This episode will focus on non–small cell lung cancer.